BDBM176761 US9675612, 8 2-Cyclohexyl-N-(1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine
SMILES: C1CCC(CC1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1
InChI Key: InChIKey=ZCZORJWUOGQOPQ-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MAP kinase-interacting serine/threonine-protein kinase 1 (T344D) (Homo sapiens (Human)) | BDBM176761 (US9675612, 8 2-Cyclohexyl-N-(1H-indazol-5-yl)[1,3]...) | PDB GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | 7.5 | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT US Patent | Assay Description For the assay 50 nL of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (... | US Patent US9675612 (2017) BindingDB Entry DOI: 10.7270/Q2RN3612 | |||||||||||
More data for this Ligand-Target Pair |